Institute of Biochemistry and Biophysics Polish Academy of Sciences Organisation/Company Institute of Biochemistry and Biophysics Polish Academy of Sciences Research Field Chemistry Researcher Profile First Stage Researcher (R1) Positions PhD Positions Application Deadline 30 Nov 2026 - 23:59 (Europe/Warsaw) Country Poland Type of Contract Temporary Job Status Full-time Hours Per Week 40 Offer Starting Date 1 Mar 2027 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description
The goal of this proposal is to determine how PTMs in the vicinity of metal-binding sites change the metal–protein binding affinity. We will also study how metal binding by the target protein affects the enzymatic efficiency of introducing and removing PTMs by kinases, phosphatases, acetyltransferases, and deacetylases. Understanding such phenomena is of relevance to diseases characterized by PTMs and metal ion dysregulation, such as cancer, as well as autoimmune, neurodegenerative, and cardiovascular diseases. The main objective of this project is to determine the interdependence of PTMs and the binding of Zn(II) and Cu(II) ions by carefully selected human proteins. The experiments on whole proteins will be complemented by research on model peptides that form metal-binding sites. Such approach will allow us to understand the observed impact in a wider context of whole intact proteins and to precisely describe the studied phenomena at the amino acid residue level. From a search of the UniProt Knowledgebase for human metal-binding proteins with known PTMs and three-dimensional structures deposited in the Protein Data Bank (PDB), we selected all proteins containing metal-binding ligands as well as sites of phosphorylation and acetylation within primary sequences up to 24 residues in length. This selection was supported by careful analysis of protein structures to ensure that the chosen fragments contain independent structural domains encompassing the complete metal coordination sphere. In the literature we found three additional modification sites for the selected Zn(II) binding proteins (Table 1). The proteins binding Cu(II) ions selected here form biologically relevant strong complexes with themetal ion via the Amino Terminal Cu and Ni binding (ATCUN) motif, where the entire coordination sphere is contained within the first three residues. Thus, we can successfully use shorter peptides for this part of the project. Table 1. Human proteins binding Zn(II) and Cu(II) ions, with known structures, and with phosphorylation or acetylation sites in proximity to metal-binding residues. Metal ion UniProt ID Name of the protein/peptide The amino acid sequence of the metal-binding site a Zn(II) Q8N884 Cyclic GMP-AMP synthase 388NNHGKSKTCCENKEEKCCRK407 236YQCQACARTFSRMSLLHKHQESGC259 Cu(II) P15515 Histatin-1 1DSHEKR6 P02768 Albumin 1DAHKSE6 Zn+Cu P05067 b A β 4-x 4FRHDSG94FRHDSGYEVHHQK16 a Phosphorylated or acetylated residues are in boldface; metal-coordinating residues are underlined; numbers represent the position in the primary amino acid sequence; b The Aβ4-x is a product of the Amyloid precursor protein processing. In the case of Cu(II)-binding peptides, we designed additional SSHSSS-am and KKHKKK-am peptides to scan every position of serine phosphorylation and lysine acetylation, respectively. Some of the peptides contain up to two modified residues. The genuine co-occurrence of such modifications is usually not resolved, but one can speculate that such co-occurrence is possible, depending on the protein’s location and lifetime. To cover all possible cases regarding experimentally confirmed PTM sites, we will test either peptide with each one PTM and the peptide with two PTMs. Thus, in addition to 13 proteins (wild-type and respective acetylation and phospho-mimetic mutants), 43 distinct peptides will be tested. Such a rich and diverse library of proteins and peptides will allow us to thoroughly analyze the influence of phosphorylation and acetylation on the binding of Zn(II) and Cu(II). Binding of Zn(II) ions by proteins and peptides Zinc ions are often labeled “silent” owing to the absence of d–d bands detectable using a UV-vis spectrophotometer. Thus, divalent cobalt ions, whose binding is iso-structural compared to Zn(II), will be utilized. The first experiment for Zn(II) binding peptides will involve their titration with Co(II), with spectrophotometric detection. Then, the Co(II)-saturated peptides will be titrated with Zn(II), which will result in a decrease of the signal from the peptide–Co(II) complex because of metal binding competition. Such “reverse titrations” will enable the calculation of the Zn(II) dissociation constant after the initial measurement of the Co(II) dissociation constant (Kd). In the case of too-strong Co(II)-binding, we will conduct additional titrations of the peptide with Ni(II) (together with Ni(II)-Co(II) competition experiments), which usually binds more weakly than Co(II) and will allow us to calculate Kd value for Co(II). Although the “reverse titration” approach does not directly reflect the biochemical situation in the organism, it is a proven tool for the characterization of Zn(II) binding. For peptides/proteins having Zn(II) dissociation constants in the μM–pM range, titrations with competitors Zincon and PAR will be performed and monitored using UV-vis spectrophotometry. Additionally, competition with EGTA will be performed and followed using spectrofluorimetry and CD spectroscopy. Fluorescence measurements will exploit the presence of phenylalanine, tryptophan, or tyrosine residues. CD spectra will monitor the overall structure of the peptide/protein. For more potent Zn(II) binding, with a Kd
Binding of Cu(II) ions by peptides Direct titration of copper(II) into the peptides at pH 7.4 will not yield measurable dissociation constants because the binding will be too strong for such analysis (Kd
Hold a degree of Master of Science [Magister], Master of Engineering [Magister Inżynier], medical doctor or equivalent in the field of: exact sciences, natural sciences, medical sciences or related disciplines, granted by a Polish or foreign university; a person who does not possess the qualifications described above may take part in the competition, but must obtain the qualifications in question and provide the relevant documents before the start of the programme at the Doctoral School (i.e., 1st March 2027). Education at the Doctoral School begins on 1st March 2027; Specific Requirements
a. the knowledge of spectrophotometry, potentiometry, and enzymology will be beneficial b. the experience in the affinity determining and recombinant protein production also will be the advantage of the candidate c. be well organized, eager to gain new knowledge and scientific skills and experience d. have fluency in spoken and written English. Languages ENGLISH Level Excellent Research Field Chemistry Additional Information
Possibility of renting a room in the Institute's hotel for the first 3 months at a special price (depending on rooms’ availability); Possibility to join a medical plan; Research mini-grants for doctoral students (up to PLN 20000, a PhD student may apply for funds twice during his/her studies); Conference Grants (each PhD student can use up to PLN 12,000 to attend conferences during his/her studies); Surcharge for the multi sport card; Support in obtaining a temporary residence card (+ Reimbursement of TRC application expenses); Language courses (Polish, English, German, French, Spanish, Italian… (the offer of courses may change); Psychological care (up to 5 visits); Subsidy for the purchase of eyeglasses (once every two years); Free parking spot. Selection process The recruitment process consists of three stages: a) selection of candidates by the Committee based on the alignment of the candidate’s competencies with the requirements specified in the recruitment program; b) selection of candidates by the Committee based on their previous achievements and academic results presented in the submitted documents; c) an interview conducted by the Committee including in particular: a presentation delivered by the candidate containing the outcomes of his/her research (a Master’s thesis or other research work carried out by the candidate); the presentation must not last longer than 10 minutes; questions asked by the members of the Committee related to the presented project, the methods used and interpretation of the results obtained; questions asked by the members of the Committee related to the proposed PhD programme described in the recruitment announcement; questions related to the candidate’s motivation for scientific work. Stage One The Committee analyzes the application documents in terms of the candidate’s competencies and their alignment with the requirements specified in the recruitment program. Candidates who obtain at least 40% of the maximum number of points in the first stage qualify for the second stage. Evaluation criteria: education in the subject areas listed in the application guidelines; (scoring scale: 0.0 – 2.0 points); experience in the subject areas listed in the recruitment program (scoring scale: 0.0 – 2.0 points); other competencies specified in the recruitment program (scoring scale: 0.0 – 1.0 points). b) Stage Two The Committee evaluates the candidates’ previous achievements and their academic performance based on the submitted documents. Candidates with the 5 best scores, not lower than 60% of the maximum number of points, will qualify for the third stage; results obtained during studies (scoring scale: 0.0 – 4.0 points) competencies specified in the recruitment programme (scoring scale: 0.0 – 3.0 points) co-authorship of a scientific publication (depending on the role in the publication) (scoring scale: 0.0 –1.0 point) other achievements, e.g., awards, active conference attendance, honourable mentions, scholarships, domestic and foreign internships, voluntary work, popularisation of science (scoring scale: 0.0 – 2.0 points) c) Stage Three: When determining the results of the interview, the Committee takes into account: the degree of understanding of one’s own work; the ability to interpret the results obtained; the understanding of the methods used, knowledge in the field related to the topic of the submitted work (a scale of the evaluation: 0 - 10 points); knowledge in the subject matter listed in the recruitment announcement (a scale of the evaluation: 0 - 10 points); form of presentation of the candidate’s results (a scale of the evaluation: 0 - 3 points). Number of offers available 1 Company/Institute Institute of Biochemistry and Biophysics Polish Academy of Sciences Country Poland State/Province Draft City Warsaw Postal Code 02-106 Street ul. Pawińskiego 5a
Procedure no. DSMBBC/2027/10 The impact of phosphorylation and acetylation of selected human protein in Warsaw – pracodawca: Institute of Biochemistry and Biophysics Polish Academy of Sciences
Instytut Biochemii i Biofizyki Polskiej Akademii Nauk to doskonały pracodawca, który oferuje wyjątkowe możliwości rozwoju zawodowego w dynamicznym środowisku badawczym. Pracując w naszym zespole, będziesz miał okazję prowadzić innowacyjne badania nad odpornością komórkową, a także współpracować z doświadczonymi naukowcami, co sprzyja wymianie wiedzy i umiejętności. Nasza kultura pracy opiera się na współpracy, wsparciu oraz dążeniu do doskonałości, co czyni nas idealnym miejscem dla osób poszukujących znaczącej i satysfakcjonującej kariery naukowej.
Dane kontaktowe:
Zespół rekrutacyjny Institute of Biochemistry and Biophysics Polish Academy of Sciences